Haemophilic arthropathy: The importance of the earliest haemarthroses and consequences for treatment

Haemophilia

Volumn 14, Issue SUPPL. 6, 2008, Pages 4-10

  Roosendaal, G ^a   Jansen, N W D ^b   Schutgens, R ^a   Lafeber, F P J G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Arthrocentesis; Haemarthrosis; Haemophilia; Prophylaxis; Treatment

Indexed keywords

CYTOKINE; GLYCOSAMINOGLYCAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; IRON; PROTEOGLYCAN; RECOMBINANT BLOOD CLOTTING FACTOR 8; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTHROCENTESIS; ARTHROPATHY; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG WITHDRAWAL; HEMARTHROSIS; HEMOPHILIA; HUMAN; JOINT PROSTHESIS; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SYNOVITIS; WEIGHT BEARING;

AGE FACTORS; AGE OF ONSET; CARTILAGE, ARTICULAR; CHILD; CHILD, PRESCHOOL; COAGULANTS; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS; IRON; PUNCTURES; SYNOVIAL MEMBRANE; TRACE ELEMENTS; YOUNG ADULT;

EID: 53249090238     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01882.x     Document Type: Article

References (28)

1. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. New Engl J Med 2007; 357: 535-44.
2. Roosendaal G, Vianen ME, Wenting MJ et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998; 80: 540-5.
3. Roosendaal G, Mauser-Bunschoten EP, de Kleijn P et al. Synovium in haemophilic arthropathy. Haemophilia 1998; 4: 502-5.
4. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997; 24: 1350-4.
5. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: A human in vitro study. Arthritis Rheum 1999; 42: 1025-32.
6. Jansen NW, Roosendaal G, Bijlsma JW, Degroot J, Lafeber FP. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: An in vitro study. Arthritis Rheum 2007; 56: 199-207.
7. Hooiveld M, Roosendaal G, Vianen M, van den Berg M, Bijlsma J, Lafeber F. Blood-induced joint damage: Longterm effects in vitro and in vivo. J Rheumatol 2003; 30: 339-44.
8. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-51.
9. Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: A canine in vivo study. Arthritis Rheum 1999;42: 1033-9.
10. Roosendaal G, Tekoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol 2000; 27: 1740-4.
11. Hooiveld MJ, Roosendaal G, Jacobs KM et al. Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: A possible mechanism of hemophilic arthropathy. Arthritis Rheum 2004; 50: 2024-31.
12. Hakobyan N, Kazarian T, Valentino LA. Synovitis in a murine model of human factor VIII deficiency. Haemophilia 2005; 11: 227-32.
13. Valentino LA, Gruber F, Hakobyan N, Enockson C, Han W. Primary human synovial cells proliferate in response to haemoglobin and whole blood. J Thromb Haemost 2007; 5 (Suppl 2): P-W-106.
14. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: Rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004; 10: 280-7.
15. Valentino LA, Hakobyan N. Histological changes in murine haemophilic synovitis: A quantitative grading system to assess blood-induced synovitis. Haemophilia 2006; 12: 654-62.
16. Valentino LA, Mejia-Carvajal C, Hakobyan N. The impact of joint bleeding and synovitis on physical ability and joint function. J Thromb Haemost 2007; 5 (Suppl. 2): P-W-107.
17. Jansen NWD, Roosendaal G, Wenting M et.al. Very rapid clearance after a joint bleed in the canine knee can not prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage 2008 (in press).
18. Jansen NWD, Roosendaal G, Hooiveld M, VanRoon J, Theobald M, Lafeber FP. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008; 142: 953-61.
19. Raffini l, Manno C. Modern management of haemophilic arthropathy. Br J Haematol 2005; 136: 777-87.
20. Wen FQ, Jabbar AA, Chen YX, Kazarian T, Patel DA, Valentino LA. c-myc proto-oncogene expression in hemophilic synovitis: In vitro studies of the effects of iron and ceramide. Blood 2002; 100: 912-6.
21. Goddard NJ, Mann H. Diagnosis of haemophilic synovitis. Haemophilia 2007; 13 (Suppl. 3): 14-19.
22. Rodriguez-Merchan EC. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. Clin Orthop Relat Res 1997; 343: 6-11.
23. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992;232: 25-32.
24. Petrini P, Lindvall N, Egberg N, Blomback M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 1991; 13: 280-7.
25. Fischer K, van der Bom JG, Mauser-Bunschoten EP et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337-41.
26. van Dijk K, van der Bom JG, Lenting PJ et al. Factor VIII half-life and clinical phenotype of severe hemophilia A. Haematologica 2005; 90: 494-8.
27. Fischer K, Van Der Bom JG, Prejs R et.al. Discontinuation of prophylactic therapy in severe haemophilia: Incidence and effects on outcome. Haemophilia 2001; 7: 544-50.
28. Van Dijk K, Fischer K, Van der Bom JG, Scheibel E, Ingerslev J, van den Berg HM. Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands. Br J Haematol 2005; 130: 107-12.